Athira Pharma, Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2021

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Athira Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2021.
  • Athira Pharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was $985K, a 1249% increase year-over-year.
  • Athira Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was $1.75M, a 468% increase year-over-year.
  • Athira Pharma, Inc. annual Nonoperating Income (Expense) for 2021 was $334K.
  • Athira Pharma, Inc. annual Nonoperating Income (Expense) for 2020 was -$1.28M, a 175% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $334K +$1.62M Jan 1, 2021 Dec 31, 2021 10-K 2022-03-28
2020 -$1.28M -$815K -175% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 -$466K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.